Spikevax (previously COVID‑19 Vaccine Moderna)
Emergency Use Authorization has been granted in Qatar for Spikevax (COVID-19 Vaccine Moderna) to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 years of age and older.
Patient Information Leaflet
Patient Information Leaflet
Summary of Product Characteristics
Summary of Product Characteristics
Storage, Handling, Dosage and Administration
Storage, Handling, Dosage and Administration
Contact Moderna
8am-5pm AST – Sun - Thr
EMEAMedinfo@modernatx.com